| Literature DB >> 32842578 |
Cintia Flores1, Josep Caixach1.
Abstract
The appearance of a bloom of cyanobacteria in the Sau-Susqueda-El Pasteral system (River Ter, NE Spain) in the autumn of 2015 has been the most recent episode of extensive bloom detected in Catalonia. This system is devoted mainly to urban supply, regulation of the river, irrigation and production of hydroelectric energy. In fact, it is one of the main supply systems for the metropolitan area of cities such as Barcelona and Girona. An assessment and management plan was implemented in order to minimize the risk associated to cyanobacteria. The reservoir was confined and periodic sampling was carried out. Low and high toxicity was detected by cell bioassays with human cell lines. Additionally, analysis studies were performed by enzyme-linked immunosorbent assay (ELISA) and liquid chromatography-high resolution mass spectrometry (LC-HRMS). A microcystin target analysis and suspect screening of microcystins, nodularins, cylindrosperpmopsin and related cyanobacterial peptides by LC-HRMS were applied. The results for the analysis of microcystins were negative (<0.3 μg/L) in all the surface samples. Only traces of microcystin-LR, -RR and -dmRR were detected by LC-HRMS in a few ng/L from both fractions, aqueous and sestonic. In contrast, different anabaenopeptins and oscillamide Y at unusually high concentrations (µg-mg/L) were observed. To our knowledge, no previous studies have detected these bioactive peptides at such high levels. The reliable identification of these cyanobacterial peptides was achieved by HRMS. Although recently these peptides are detected frequently worldwide, these bioactive compounds have received little attention. Therefore, more studies on these substances are recommended, especially on their toxicity, health risk and presence in water resources.Entities:
Keywords: LC–HRMS; Orbitrap; anabaenopeptins; bloom; cyanobacteria; cyanobacterial peptides; microcystins; oscillamide Y
Mesh:
Year: 2020 PMID: 32842578 PMCID: PMC7551688 DOI: 10.3390/toxins12090541
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Results of the target analysis of microcystins obtained by LC–HRMS for aqueous fractions.
| Concentration | Sample Reference | LOQ | ||||||
|---|---|---|---|---|---|---|---|---|
| Input DWTP | Costa Brava Tank | Dam | A1 | M1 | M2 | M3 | ||
| Reservoir | El Pasteral | Susqueda | Sau | |||||
| MC-dmRR | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | 0.3 |
| MC-RR | n.d. | n.d. | n.d. | <0.01 * | <0.01 * | <0.01 * | <0.01 * | |
| MC-dmLR | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
| MC-YR | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
| MC-LR | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | <0.01 * | |
| MC-WR | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
| MC-LA | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
| MC-LY | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
| MC-LW | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
| MC-LF | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | n.d. | |
n.d.: not detected; MC: microcystin; LOQ: limit of quantitation (direct injection and LC–HRMS analysis); DWTP: Drinking Water Treatment Plant; * the concentration was estimated by extrapolation.
Results of the target analysis of microcystins obtained by LC–HRMS for sestonic fractions of Sau samples.
| Concentration | Sample Reference | LOQ | ||
|---|---|---|---|---|
| M1 | M2 | M3 | ||
| MC-dmRR | n.d. | n.d. | <LOQ (0.4) * | 10 |
| MC-RR | n.d. | n.d. | <LOQ (0.4) * | |
| MC-dmLR | n.d. | n.d. | n.d. | |
| MC-YR | n.d. | n.d. | n.d. | |
| MC-LR | n.d. | n.d. | n.d. | |
| MC-WR | n.d. | n.d. | n.d. | |
| MC-LA | n.d. | n.d. | n.d. | |
| MC-LY | n.d. | n.d. | n.d. | |
| MC-LW | n.d. | n.d. | n.d. | |
| MC-LF | n.d. | n.d. | n.d. | |
n.d.: not detected; MC: microcystin; LOQ: limit of quantitation (pre-concentration by methanol extraction and LC–HRMS analysis); * the concentration was estimated by extrapolation.
Results of the suspect screening analysis of cyanobacterial peptides obtained by LC–HRMS for sestonic fractions of Sau samples.
| Estimated | Sample Reference | ||
|---|---|---|---|
| M1 | M2 | M3 | |
| Anabaenopeptin C | 2.6 | 0.03 | n.d. |
|
|
| ||
| Anabaenopeptin B | 30 | 0.5 | 0.7 |
| Anabaenopeptin F | 58 | 1.1 | 2.2 |
| Anabaenopeptin A | 4.9 | 0.1 | 0.1 |
| Oscillamide Y | 13 | 0.2 | 0.2 |
n.d.: not detected.
Figure 1Extracted ion chromatograms and mass spectra of ocillamide Y and anabaenopeptins A, B and F detected in sample M1 (superficial scums) by LC–HRMS.
Figure 2Product ion spectra of anabaenopeptin F (exact m/z of [M+H]+: 851.4774) detected in sample M1 (superficial scums) by LC–HRMS in the all ion fragmentation (AIF) acquisition mode at: 30 eV (a) and 70 eV (b).
Figure 3Product ion spectra of ocillamide Y (exact m/z of [M+H]+: 858.4396) detected in sample M1 (superficial scums) by LC–HRMS in the AIF acquisition mode at: 30 eV (a) and 70 eV (b).
Figure 4Sampling map.